抗血小板的
Antiplatelet therapy is recommended for symptomatic patients. 推薦抗血小板治療癥狀性患者。
Conclusion: The antiplatelet drugs utilization needs further standardization. 結(jié)論:臨床需進一步規(guī)范使用抗血小板藥物。
Evidence based case report Should a patient with primary intracerebral haemorrhage receive antiplatelet or anticoagulant therapy? 原發(fā)性腦出血患者是否應(yīng)該進行抗血小板或抗凝治療?
Antiplatelet Therapy for Secondary Prevention of Cardiovascular Events: More "Advanced" Drug, More Perfect? 心血管事件的二級預(yù)防:抗血小板治療藥物越“先進”越完美嗎?
Title:Can antiplatelet prophylaxis reduce the incidence of hepatic artery thrombosis after liver transplantation? 抗血小板預(yù)防可否減少肝移植術(shù)后肝動脈栓塞的發(fā)生率?